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Abstract
Dietary fat, both in terms of quantity and quality, has been implicated to cancer development, either positively or
negatively. The aim of this work was to evaluate whether olive oil or monounsaturated fat intake was associated
with the development of cancer. A systematic search of relevant studies, published in English, between 1990 and
March 1, 2011, was performed through a computer-assisted literature tool (i.e., Pubmed). In total 38 studies were
initially allocated; of them 19 case-control studies were finally studied (13800 cancer patients and 23340 controls
were included). Random effects meta-analysis was applied in order to evaluate the research hypothesis. It was
found that compared with the lowest, the highest category of olive oil consumption was associated with lower
odds of having any type of cancer (log odds ratio = -0.41, 95%CI -0.53, -0.29, Cohran’s Q = 47.52, p = 0.0002, I-sq =
62%); the latter was irrespective of the country of origin (Mediterranean or non-Mediterranean). Moreover, olive oil
consumption was associated with lower odds of developing breast cancer (logOR = -0,45 95%CI -0.78 to -0.12),
and a cancer of the digestive system (logOR = -0,36 95%CI -0.50 to -0.21), compared with the lowest intake. The
strength and consistency of the findings states a hypothesis about the protective role of olive oil intake on cancer
risk. However, it is still unclear whether olive oil’s monounsaturated fatty acid content or its antioxidant
components are responsible for its beneficial effects.
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Introduction
Dietary fat, both in terms of quantity and quality, has
been implicated to cancer development, either positively
or negatively. Monounsaturated and polyunsaturated
fats, deriving from olive oil and fish oil respectively, are
among those that data are emerging for their relation to
certain cancer types [1-3]. Concerning olive oil, no
answer still exists as to whether the monounsaturated
fatty acid content or the antioxidant components of its
unsaponifiable fraction are responsible for its beneficial
effects. Its fatty acid composition is mainly oleic acid,
followed by palmitic and linoleic acids [4]. In addition,
extra-virgin olive oil contains phenolic antioxidants,
including simple phenols, aldehydic secoiridoids, flavo-
noids and lignans [5,6]. The high content of oleic acid
makes olive oil far less susceptible to oxidation than the
polyunsaturated fatty acids, for example. Also, olive oil’s
most representative phenols are thought to be potent
scavengers of superoxide and other reactive species, a
possible step for mutagenesis [7].
The effect of olive oil on human health has, till now,
mainly been analyzed by studies deriving from Mediter-
ranean populations, where it is consumed in large quan-
tities. Almost all studies do not distinguish between
‘plain’ olive oil, which is the most used in the world
market, and extra-virgin olive oil. Moreover, as it has
been already stated, before causally interpreting the
usually observed inverse association of olive oil to
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well as other limitations arising from the fact that asso-
ciations are reported mainly from case-control studies
[8].
To the best of our knowledge, there is no published
systematic review and meta-analysis regarding the effect
of olive oil consumption on cancer occurrence. Thus,
the aim was to evaluate whether olive oil intake is asso-
ciated with various types of cancer.
Methods
Studies selection and data extraction
Original research studies published in English between
1990 and March 1, 2011 were selected through a com-
puter-assisted literature search (i.e., Pubmed, http://
ncbi.nlm.nih.gov/PubMed). Combinations of key
words relating to the aim of the paper were used, i.e.
olive oil, Mediterranean diet, and cancer, or neo-
plasms. Also, specific searches are included: olive oil
and, alternatively, prostate cancer, cancer of the lar-
ynx, oral carcinoma, cancer of the pharynx, cancer of
the oesophagus, stomach cancer, lung cancer, ovarian
cancer, renal cancer, endometrial cancer, pancreatic
cancer, breast cancer, colorectal cancer, skin cancer,
bladder cancer, haematological malignancies, leukae-
mia. In addition, the reference list of the retrieved
articles was in some cases used to find articles not
already allocated. The following information was
abstracted according to a fixed protocol: study design,
sample size, mean age and gender of participants, fol-
low-up duration, assay methods, effect size measure-
ments and potential confounders. The initial search
(01.01.1990-01.03.2011, English language, humans)
resulted in 248 entries on olive oil and cancer, 188
entries on olive oil and neoplasms, 297 entries on
Mediterranean diet and cancer and 194 entries on
Mediterranean diet and neoplasms. From the finally
included papers, 3 were prospective, 35 were case-
controls and none was a clinical trial. For the papers
that they were not fully available in PubMed the infor-
mation was retrieved from the abstract. This systema-
tic review follows a cancer-specific structure; all
papers referring to olive oil are included, and all
papers referring to monounsaturated fats in Mediter-
ranean countries are included too, because a substan-
tial proportion of monounsaturated fat in traditional
Mediterranean countries derives from olive oil. Finally,
papers referring to the cancer risk examining the
monounsaturated to saturated fats ratio were not
taken into account, because this ratio is a proxy for
olive oil intake, but not a definite evidence for its use
and, thus, its beneficial effects. In addition, for the
meta-analysis of the selected studies the MOOSE
guidelines have been taken into account [9].
Statistical analysis
R e s u l t so ft h es t u d i e sa r ep r e s e n t e da so d d sr a t i o sa n d
their corresponding standard errors (SE) or 95% confi-
dence intervals. From the finally included 38 papers (3
were prospective and 35 were case-controls), the meta-
analysis was focused only on studies (n = 19) that solely
evaluated raw olive oil intake, in order to eliminate the
potential synergistic effect of cooking. Random effects
meta-analysis of the selected studies was applied. The
effect size measures used for the meta-analysis were the
log-odds ratios (and the corresponding SE) of olive oil
intake (highest vs. lowest available category) and the
endpoints of the selected studies were cancers of above
mentioned specified topographies. Heterogeneity was
assessed using Cochran’sQa n dI
2 (I
2 ranges between
0% and 100%, with lower values representing less het-
erogeneity) and evaluated using the chi-squared test.
Sensitivity analyses were performed according to some
characteristics of the studies, such as: country of origin
(Mediterranean or not) and type of cancer. To assess
the presence of publication bias, the “funnel’sp l o t ” was
tested. All statistical calculations were performed using
NCSS 2004 software (Number Cruncher Statistical Sys-
tems Co., Utah, USA).
Results
Table 1 summarizes studies’ characteristics. The major-
ity of the studies that completed the entry criteria for
this review were case - control (i.e., 35), while only three
were prospective.
In Table 2 the main findings of each study are
summarised.
Breast cancer
Several case-control studies, conducted in Greece, Spain,
Italy and France suggest that olive oil may be associated
with decreased breast cancer. In a Greek hospital-based
case-control study of 820 women with breast cancer and
1548 controls, after adjustment for energy intake, more
frequent consumption of olive oil was associated with
significantly reduced breast cancer risk (odds ratio, OR
= 0.75) for more than once a day compared with once a
day. This protective association was concentrated in
postmenopausal women, but the relevant interaction
term was not statistically significant [10]. Evaluating spe-
cifically the relation of monounsaturated fat intake with
breast cancer, no suggestive association was shown
(mutually adjusted RR per quintile 0.97, 95%CI 0.88 to
1.07) [11]. Furthermore in Greece, Trichopoulou et al.
[12] studied the relation of conformity to the Mediterra-
nean diet with breast cancer risk in the context of the
European Prospective Investigation into Cancer and
N u t r i t i o nc o h o r ti nG r e e c e .F o u r t e e nt h o u s a n d se i g h t
hundred women were followed up for an average of 9.8
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Author Year
published
Design, region and follow-up
duration
Sample size; mean age and gender;
histological evaluation
Assay methods
Breast cancer
Trichopoulou
A, et al [10]
1995 Case-control study conducted in
Greece from 1989 to 1991
820 women with breast cancer and
1548 controls
Olive oil intake more than once a day
versus once a day. A semiquantitative
questionnaire is used.
Katsouyanni
K, et al [11]
1994 Hospital-based case-control study
conducted in Greece from 1989 to
1991
820 patients with histological
confirmed cancer of the breast were
compared with 795 orthopaedic patient
controls and 753 hospital visitor
controls
Diet was ascertained through a semi-
quantitative food-frequency
questionnaire; quintiles of
monounsaturated fat were measured.
Trichopoulou
A, et al [12]
2010 Prospective study which evaluated
the relation of conformity to the
Mediterranean
diet with breast cancer risk in the
context of the European Prospective
Investigation into Cancer and
Nutrition cohort in Greece
14,807 women were followed up for an
average of 9.8 y and
identified 240 incident breast cancer
cases
Diet was assessed
through a validated food-frequency
questionnaire, and conformity
to the Mediterranean diet was
evaluated through a score (range = 0-9
points) incorporating the characteristics
of this diet. Among others, intake of
olive oil and monounsaturated lipids
were measured.
Martin-
Moreno JM,
et al [13]
1994 Population-based case-control study
conducted in Spain
762 patients (18-75 years of age) and
988 female controls
Quartiles of olive oil consumption.
Landa MC, et
al [14]
1994 Case-control study conducted in
north Spain from 1988 to 1991
100 women with breast cancer and 100
hospital controls
Tertile of monounsaturated fat intake
were measured.
García-
Segovia P, et
al [15]
2006 Case-control study conducted in
Spain from 1999 to 2001
755 women: 291 incident cases with
confirmed breast cancer and 464
controls randomly selected from the
Canary Island Nutrition Survey
A semi-quantitative food-frequency
questionnaire was completed; intake of
monounsaturated fat and olive oil were
measured.
La Vecchia C,
et al. [16]
1995 Multicenter case-control study
conducted between 1991 and 1994
in Italy
2564 histological confirmed patients
and 2588 controls (aged 34-70 years)
Use of a validated food-frequency
questionnaire; olive oil was measured.
Sieri S, et al
[17]
2004 Prospective study conducted in
northern Italy where women
volunteers were recruited from 1987
to 1992 and were followed for 9.5
years
8,984 women were followed up for an
average of 9.5 y, and identified 207
incident breast cancer cases
A semiquantitative
food frequency questionnaire was used
for the evaluation of four dietary
patterns. Olive oil consumption was
assessed in the salad vegetables
pattern.
Bessaoud F,
et al [18]
2008 Case-control study conducted in
southern France (June 2002 to
December 2004)
437 histological confirmed patients and
922 controls females, aged 25 to 85
years
Olive oil intake was assessed through a
validated food-frequency questionnaire.
Richardson S,
et al [20]
1991 Hospital-based case-control study
conducted in France
409 patients and 515 controls Tertile of consumption of
monounsaturated fat intake was
measured.
Colorectal cancer
Braga C, et al
[25]
1998 Multicenter case-control study in six
Italian areas from 1992 to 1996
1953 patients with histological
confirmed colorectal carcinoma (1225
of the colon and 728 of the rectum)
(median age 62 years, range 23-74).
Controls were 4154 subjects with no
history of cancer (median age 58 years,
range 20-74).
Tertiles of olive oil intake were
measured. Olive oil intake was assessed
through a food-frequency questionnaire
including 78 foods, groups of foods or
recipes.
Benito E, et al
[29]
1991 Multicenter case-control study of
colorectal cancer conducted in Spain
from 1984 to 1988
286 colorectal cancer cases, 295
population controls and 203 hospital
controls
Different monounsaturated fat intakes
were measured. Food composition
tables and ad-hoc estimates of portion
sizes were used to derive intake
estimates of 29 nutrients and of total
calories.
Galeone C, et
al [30]
2007 Multicenter case-control study of
colorectal cancer conducted in Italy
and Switzerland from 1992 to 2000
1394
cases of colon cancer (median 62
years), 886 cases of rectal cancer
(median 63 years) and 4765 controls
(median 58 years)
Use of fried olive oil was measured.
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Prostate cancer
Tzonou A, et
al [34]
1999 Case-control study conducted from
1994 to 1997 in Greece
320 patients with histological
confirmed prostate cancer and 246
controls (aged 71 years and 70 years,
respectively)
Olive oil and other fat were measured.
The food-frequency questionnaire
comprised around 120 food items or
beverages categories.
Norrish AE, et
al [35]
2000 Population-based case-control study
conducted in New Zealand from
1996 to 1997
317 prostate cancer cases and 480
controls from 40 to 80 years old
Quantiles of monounsaturated fat-rich
vegetable oil consumption were
measured.
Hodge A, et
al [36]
2004 Population-based case-control study,
where eligible cases were diagnosed
between 1994 and 1997 in Australia
858 men aged < 70 years with
histological confirmed cancer and 905
age-frequency-matched men, selected
at random from the electoral rolls
Various olive oil intakes were measured.
Food-frequency questionnaire had 121-
items.
Cancer of the larynx
Gallus S, et al
[40]
2003 Combined dataset from two case-
control studies conducted from 1986
to 2000 in northern Italy and
Switzerland
68 women under age 79 years, with
incident, histological confirmed cancer
of the larynx (median age 60 years).
Controls were 340 women, admitted to
the same network of hospitals (median
age 60 years)
Intake of olive oil was measured.
Validated food-frequency questionnaire
based on 78 foods or groups of foods
was applied.
Crosignani P,
et al [41]
1996 Prospective study to evaluate survival
for laryngeal cancer cases
interviewed 10 years ago in a
population-based case-control study
213 incident cases of laryngeal cancer Olive oil and other fat were measured
through a food frequency
questionnaire.
Bosetti C, et
al [43]
2002 Case-control study conducted in
Nothern Italy and the Swiss Canton
of Vaud from 1992 to 2000
527 histological confirmed cases and
1297 frequency-matched controls
Dietary intakes 2 years prior to cancer
diagnosis were estimated through a
food-frequency questionnaire including
78 foods and beverages. Olive oil
consumption was measured.
Cancer of the oral cavity and pharynx
Lagiou P, et
al [44]
2009 Multicenter case-control study in 14
centers in 10 countries, 2002 to 2005
in all centers but Paris (1987 to 1992)
1861 men and 443 women histological
confirmed cancer patients and 1661
men and 566 women controls that
were frequency-matched to patients by
sex, and
5-year groups.
Olive oil consumption was recorded
through a semi-quantitative food
frequency questionnaire, specifically
developed for ARCAGE. Olive oil was
not recorded in the Paris center.
Franceschi S
et al [46]
1999 Multicenter case-control in Italy
carried out in 1992 to 1997
512 men and 86 women oral cavity
and pharynx cancer cases (median age
58, range 22-77) and 1008 men and
483 women controls (median age 57,
range 20-78)
Food-frequency questionnaire included
78 foods, food groups or recipes,
including olive oil intake.
Nešić V, et al
[47]
2010 Case-control study conducted
in Belgrade of Serbia, during the
period 2001-2003
45 cases with histopathological
diagnosis of UCNT and 90 controls that
were matched by sex, age (± 3 years),
and place of residence (city-village)
Dietary data were
collected using a food frequency
questionnaire (FFQ) included 100 food
items. Olive oil consumption was
measured.
Petridou E, et
al [48]
2002 Hospital-based case-control study in
Greece
106 patients and 106 control subjects. Different intakes of added lipids (olive
oil is a substantial fraction) were
measured. Dietary intake was assessed
through a validated, semi-quantitative
food-frequency questionnaire.
Cancer of the oesophagus
Tzonou A, et
al [50]
1996 Hospital-based case-control study
conducted in Greece from 1989 to
1991
99 patients (43 patients with incident
esophageal squamous-cell carcinoma
and 56 patients with incident
esophageal adenocarcinoma) and 200
controls
The frequency of intake of
monounsaturated fats was measured.
Diet was assessed through a
semiquantitative food-frequency
questionnaire.
Bosetti C, et
al [51]
2000 Multicenter case-control study in 3
areas of northern Italy from 1992 to
1997
304 patients (275 men, 29 women)
(median age 60, range 39-77) and 743
controls (593 men, 150 women)
(median age 60, range 36-77)
Olive oil intake was measured through
a food-frequency questionnaire that
included 78 specific foods and
beverages.
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Results showed that although increasing conformity to
the Mediterranean diet was not associated with lower
breast cancer risk in the entire cohort, however there
was a marginally significant inverse association among
postmenopausal women (HR = 0.78 for every 2 points;
95%CI 0.62 to 0.98). Moreover, results showed that the
increased consumption of olive oil was associated with
lower breast cancer risk in the entire cohort (HR = 0.93,
95%CI 0.80 to 1.08) and in the postmenopausal women
(HR = 0.85, 95%CI 0.69 to 1.06) respectively, though not
statistically significant [12].
Table 1 A summary of the selected studies according to the year published, design, region, follow-up, sample?’?s
characteristics and assay methods used. (Continued)
Launoy G, et
al
53
1998 Multicenter case-control study
conducted between 1991 and 1994
in France
208 histological confirmed patients and
399 controls, all males
Different types of olive oil intake were
measured through a standardized
detailed food questionnaire about the
previous year’s diet.
Stomach cancer
Palli D, et al
[54]
2001 Population-based case-control study
in Italy conducted between 1985-
1987
126 patients with MSI status (MSI + =
43, MSI- = 83) and 561 controls
Tertiles of olive oil consumption and
other lipids were measured.
Lung cancer
Fortes C, et al
[56]
2003 Hospital-based case-control study
conducted in Italy from1993 to 1996
Cases were 342 patients with newly
diagnosed primary lung cancer and
controls were 292 adults (all aged more
than 35 years)
Olive oil intake was measured.
Ovarian cancer
Tzonou A, et
al [60]
1993 Hospital-based case-control study
conducted in Greece from 1989 to
1991
189 patients and 200 controls under 75
years of age
Monounsaturated fat and other lipids
were measured.
Bosetti C, et
al [61]
2002 Multicenter case-control study,
conducted from January 1992 to
September 1999
1031 histological confirmed patients
(median age 56, age range 18-79 years)
and 2411 hospital controls (median age
57, age range 17-79 years).
Seasonal lipid consumption, such as
olive oil and other fats were measured.
The specific food-frequency
questionnaire included 78 specific
foods and beverages.
Endometrial cancer
Levi F, et al
[65]
1993 Case-control study conducted in
Switzerland and northern Italy
274 histological confirmed patients and
572 controls
Olive oil intake was measured. Diet was
assessed using a questionnaire which
considered 50 indicator foods,
including the major sources of energy.
Tzonou A, et
al [66]
1996 Hospital-based case-control study
undertaken in Greece from 1992 to
1994
145 histological confirmed patients and
298 controls
Intake of monounsaturated fat, mostly
olive oil was measured.
Petridou E, et
al [67]
2002 Hospital-based case-control study
undertaken in Greece
84 histological confirmed patients and
84 controls with intact uterus
Olive oil was measured.
Pancreatic cancer
Kalapothaki V,
et al [68]
1993 Hospital-based case-control study
conducted in Athens from 1991 to
1992
181 cases and 181 hospital-181 hospital
visitor controls
Monounsaturated fat was measured.
Food-frequency questionnaire was
assessing the consumption of 110 food
items or beverages over the period of
one year before the onset of the
disease.
Soler M, et al
[69]
1998 Case-control study conducted in Italy
between 1983 and 1985
362 patients with histological
confirmed cancers of the pancreas and
1552 controls
Tertiles of olive oil intake were
measured.
La Vecchia
and Negri
[70]
1997 Case-control study conducted in Italy
between 1983 and 1985
362 patients with histological
confirmed cancers of the pancreas and
1502 controls
Tertiles of olive oil intake were
measured.
Bladder cancer
Brinkman MT
et al [74]
2011 Case-control study conducted in
Belgium
200 cases and 386 controls Tertiles of olive oil intake were
measured.
Riboli E et al
[75]
1991 Multi-centre case-control study
conducted in Spain
432 male cases and 792 age matched
controls
Monounsaturated fat intake was
measured. Usual dietary habits were
investigated by means of an interview-
based dietary history questionnaire.
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Author Effect sizes
(OR = odds ratio)
95% Confidence
Interval
Confounding factors
Breast cancer
Trichopoulou
A, et al [10]
Increased olive oil consumption is related with
reduced cancer risk (OR = 0.75 for more than once a
day versus once a day)
0.57-0.98 Adjustment for age, place of birth, parity, age at first
pregnancy, age at menarche, menopausal status,
Quetelet index, total energy intake, consumption of
fruits and vegetables
Katsouyanni
K, et al [11]
OR per quintile monounsaturated fat 0.97 0.88-1.07 Adjustment for demographic and reproductive risk
factors for breast cancer, as well as for total energy
intake and mutual confounding influences among
nutrients
Trichopoulou
A, et al [12]
HR per 21 g in daily intakes of olive oil in the entire
cohort (HR = 0.93, P = 0.106) and in the
postmenopausal women (HR = 0.85, P = 0.106)
0.80-1.08
0.69-1.06
Adjusted for age, educational level, smoking status,
BMI, height (ordered as quintiles), metabolic
equivalents of task hours per day, energy intake, age of
menarche, parity, age at first delivery, menopausal
status, age at menopause, hormone replacement
therapy and an interaction term for the BMI by
menopausal status.
Martin-
Moreno JM,
et al [13]
For highest versus lowest quartile of olive oil
consumption, OR = 0.66
0.46-0.97 Adjustment for total energy intake and other potential
confounders
Landa MC, et
al [14]
OR for the highest tertile of monounsaturated fat
intake compared to the lowest 0.30
0.1-1.08 Not mentioned in the abstract in PubMed
García-
Segovia P, et
al [15]
The OR for women in the three upper quintiles of
olive oil consumption (≥ 8.8 g/day) is 0.27
OR for monounsaturated fat intake is 0.52
0.17-0.42
0.30-0.92
Not mentioned in the abstract in PubMed
La Vecchia C,
et al [16]
OR per unit (30 g) is 0.89. The ORs for olive oil
compared with the lowest intake are 1.05, 0.99, 0.93
and 0.87 for increasing quintiles of intake.
0.81-0.99 Adjusted for demographic and reproductive breast-
cancer risk factors, energy intake and mutually for
types of dietary fat
Sieri S, et al
[17]
The salad vegetables pattern had a RR = 0.66 0.47-0.95 Adjusted for education, parity, height, age at
menarche, smoking, menopausal status, energy intake
and age
Bessaoud F,
et al [18]
OR (> 20.5 g/day vs. < 2 g/day) 0.71 (classical method)
OR (> 20.5 g/day vs. < 2 g/day) 0.29 (spline method)
0.44-1.14
0.18-0.47
Adjustment for total energy intake, education, parity,
breast-feeding age at first full-term pregnancy, duration
of ovulatory activity, body mass index, physical activity,
and first-degree family history of breast cancer.
Adjustment by monounsaturated fatty acids and total
energy intake
Richardson S,
et al [20]
OR for the highest tertile of consumption of mono-
unsaturated fat = 1.7
1.2-2.5 Not mentioned in the abstract in PubMed
Colorectal cancer
Braga C, et al
[25]
ORs for the highest tertile of olive oil intake, compared
with the lowest one is 0.83 when colorectal carcinoma
is analyzed
as a whole/0.81 for colon carcinoma and 0.88 for
rectal carcinoma
ORs are 0.94 for colorectal
0.94 for colon carcinoma
0.97 for rectal carcinoma
0.70-0.99
0.66-0.99
0.66-1.12
0.79-1.12
0.76-1.16
0.75-1.25
Estimates from multiple logistic regression equations
are presented, including terms for study center, age,
sex, education, alcohol, total energy intake, and
simultaneously the various types of oils and fats.
After allowance for vegetable intake.
Benito E, et al
[29]
ORs for the higher available category of
monounsaturated fat intake compared for the lowest
one is 0.72
Not mentioned in
the abstract in
PubMed
Adjustment for total calorie intake
Galeone C, et
al [30]
OR for fried olive oil, 0.89, for colon cancer 0.82-0.98 Adjusted for age, center, sex, education, body mass
index, tobacco smoking, alcohol drinking, non alcohol
energy intake, family history, physical activity and red
meat intake.
Prostate cancer
Tzonou A, et
al [34]
Chi-square linear trend adjusted = 0.44 Adjusted for age, height, Quetelet index, years of
schooling and total energy intake.
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Norrish AE, et
al [35]
RR 0.5 (> 5.5 ml MUFA-rich vegetable oil intake per
day vs. non-consumption)
0.3-0.9 The multivariate linear regression model included
terms for age, total non-steroidal anti-inflammatory
drugs, socioeconomic status, intake of total energy,
lycopene, and levels of eicosapentaenoic acid and
docosahexaenoic acid measured in erythrocytes
Hodge A, et
al [36]
Higher consumption of olive oil (> 0.25, as well as <
0.25 l/month compared to non consumption) had an
OR = 0.8
0.6-1.1 Adjusted for state, age group, year, country of birth,
socioeconomic group, total energy intake and family
history of prostate cancer
Cancer of the larynx
Gallus S, et al
[40]
OR for the olive oil higher intake compared to the
lower one was 0.28
0.09-0.89 Adjusted for age, year of interview and study center,
and including terms for education, BMI, non-alcohol
energy intake, tobacco and alcohol consumption
Crosignani P,
et al [41]
The consumption of olive oil was associated with a
better prognosis from laryngeal cancer
Not mentioned in
the abstract in
PubMed
Not mentioned in the abstract in PubMed
Bosetti C, et
al [43]
OR = 0.4 for the highest compared to the lowest
quintile
When adjusted for total vegetable consumption: OR =
0.66
0.3-0.7
0.39-1.09
Estimates from unconditional logistic regression
adjusted for sex, age, center, education, tobacco
smoking, alcohol drinking, non-alcohol energy intake,
all seasoning fats in the table, as well as for total
vegetable consumption in the second model.
Cancer of the oral cavity and pharynx
Lagiou P, et
al [44]
Center specific median was used as a cut-off. For olive
oil above versus below median:
Olive oil (overall) OR 0.78
Olive oil in salads OR 0.84
Olive oil for cooking OR 0.65
0.67-0.90
0.70-1.00
0.55-0.78
Adjusted for centre through stratification and
controlled for age, gender, BMI, height, education level,
alcohol consumption and smoking status.
Franceschi S
et al [46]
Olive oil OR = 0.4
(highest vs. lowest quintile)
Vegetable-adjusted OR = 0.6 for the same quintiles
0.3-0.7
0.4-0.9
Adjusted for age, centre, sex, education, smoking habit,
total intake of alcohol and energy, plus all oils and fats
examined.
Nešić V, et al
[47]
For frequent/moderate consumption vs. rare or never,
OR 0.42
0.19-0.91 Variables, which were significantly associated
with nasopharyngeal cancer in each of the multivariate
analyses, were included in the final model
(consumption frequency of eggs, margarine, olive oil,
rice, white bread,
cornbread, peanuts and industrially manufactured food
additives for enhancing flavour, as well as “passive
smoking” in the family during childhood, chronic
rhinosinusitis and
positive family history for malignant tumours outside
of the otorhinolaryngology region)
Petridou E, et
al [48]
Added lipids, which in Greece are overwhelmingly
olive oil, OR = 0.75 (per quantile of intake)
0.58-0.99 Adjusted for body mass index, height, years of
schooling, condition of teeth, energy intake, tobacco
smoking, daily alcohol and coffee consumption and
total energy intake.
Cancer of the oesophagus
Tzonou A, et
al. [50]
OR associated with an increment of a marginal
quintile in the frequency of intake of
monounsaturated fat is 1.07 for adenocarcinoma of
the oesophagus.
The respective OR is 0.74 for squamous cell carcinoma
0.72-1.60
0.49-1.11
Adjusted for socio-demographic facts, tobacco
smoking, consumption of alcoholic beverages and total
energy intake
Bosetti C, et
al. [51]
OR = 0.36 for the highest compared to the lowest
quintile
0.18-0.73 Adjusted for age, sex, area of residence, education,
tobacco smoking, alcohol drinking, non-alcohol energy,
all added lipids and for total energy consumption
Launoy G, et
al [53]
OR for consumers versus non-consumers 0.70 0.54-0.90 Adjusted for age, interviewer, smoking, beer, aniseed
aperitifs, hot Calvados, whisky, total alcohol, total
energy intake and other food groups.
Stomach cancer
Palli D, et al
[54]
OR = 0.6, for the highest versus the lowest tertile
(MSI-)
OR = 0.5, for the highest versus the lowest tertile
(MSI+)
0.3-1.00
0.2-1.1
Adjusted for age, sex, social class, family history of
gastric cancer, area of residence, and BMI tertiles, and
total energy.
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first one (762 cases - 988 controls), for olive intake, the
odds ratios for the highest versus the lowest quartile of
consumption was 0.66, with a significant dose-response
trend [13]. In the second (100 breast cancer cases - 100
controls), women in the highest tertile of monounsatu-
rated fat consumption were at lower risk compared with
women in the lowest tertile (RR = 0.30; 95%CI 0.1 to
1.08) [14]. At last, in the Canary Islands study, the odds
ratio for women in the three upper quintiles of olive oil
consumption (≥ 8.8 g/day) was 0.27 [15]. In Italy, in a
multicenter case-control study (2564 cases - 2588 con-
trols), the odds ratio per unit (30 g) increase of olive oil
consumption was 0.89 (95%CI 0.81 to 0.99); the ORs for
increasing levels of olive oil consumption, adjusted for
total calories, were found as 1.05, 0.99, 0.93 and 0.87
[16]. In the same country, in a prospective study that
used nutritional data from 8984 women, an average
Table 2 Effect size measures and confounding factors used in the selected studies that were included in the systema-
tic review. (Continued)
Lung cancer
Fortes C, et al
[56]
Exclusive use of olive oil OR = 0.67 0.45-0.99 Adjusted for smoking variables and also considering all
food items simultaneously
Ovarian cancer
Tzonou A, et
al [60]
The adjusted OR associated with an increment of
about 1 SD of the energy-adjusted residual of
monounsaturated fat
was 0.80
0.65-0.99 Adjusted for age, years of schooling, parity, age at first
birth, menopausal status, as well as for energy intake
and other nutrients in the same model, such as crude
fiber.
Bosetti C, et
al [61]
A reduced risk of ovarian cancer was observed for the
highest quintile of olive oil OR = 0.68 compared to
the lowest one.
OR were 0.85 for olive oil per 12 gr.
Allowance for total vegetable intake attenuated the
effect
OR = 0.82
0.50-0.93
0.76-0.95
0.60-1.14
Adjusted for study centre, year at interview, age,
education, parity, oral contraceptive use, and total
energy intake, various types of added oils and fats
simultaneously, plus total vegetable intake, when
indicated.
Endometrial cancer
Levi F, et al
[65]
OR for the highest versus the lowest tertile of olive oil
intake OR = 0.82
Not mentioned in
the abstract in
PubMed
Not mentioned in the abstract in PubMed
Tzonou A, et
al [66]
Increasing intake of monounsaturated fat, mostly olive
oil, by about one standard deviation was associated
with a OR = 0.74
0.54-1.03 Adjusted for age, schooling years, age at menopause,
number of liveborn children, number of miscarriages,
number of abortions, history of use of menopausal
estrogens, smoking, alcohol intake, coffee drinking,
height, body mass index and energy intake, as well as
for protein, saturated and polyunsaturated fat
Petridou E, et
al [67]
Highly suggestive protective effect of added lipids,
which in the Greek diet are primarily represented by
olive oil
Not mentioned in
the abstract in
PubMed
Not mentioned in the abstract in PubMed
Pancreatic cancer
Kalapothaki V,
et al [68]
OR = 1.04 (hospital controls)
OR = 0.97 (visitor controls)
These are associated with an increment of about one
standard deviation of the energy-adjusted residual of
monounsaturated fat intake
0.86-1.25
0.80-1.17
Controlling for age, gender, hospital, past residence,
years of schooling, cigarette smoking, diabetes mellitus
and energy intake
Soler M et al
[69]
OR = 0.58 0.35-0.97 Adjusted for socio-demographic factors and smoking
La Vecchia
and Negri
[70]
OR 0.76 for the intermediate
OR 0.60 for the highest score of intake
Not mentioned in
the abstract
available in
Pubmed
Not mentioned in the abstract in Pubmed
Bladder cancer
Brinkman MT,
et al [74]
Comparing the highest with the lowest tertiles of olive
oil intake between cases and controls using
unconditional logistic regression. Middle versus the
lowest tertile (OR: 0.62; and the highest versus the
lowest tertile (OR: 0.47, p-trend = 0.002)
0.39-0.99
0.28-0.78
Adjustment was made for age, sex, smoking
characteristics, occupational exposures and calorie
intake
Riboli E et al
[75]
Moderate increases in the risk for higher intake of
monounsaturated fat were found, which disappeared
after correction for saturated fat
Not mentioned in
the abstract in
PubMed
Adjusted for tobacco smoking and energy intake.
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Page 8 of 16follow-up of 9.5 years and 207 incident cases of breast
cancer, the participants completed a semiquantitative
FFQ, during 1987 to 1992 (ORDET cohort). The “salad
vegetables” pattern, principally consisting of raw vegeta-
bles and olive oil, was associated with significantly lower
(34-35%) breast cancer incidence (RR = 0.66, 95%CI
0.47 to 0.95), comparing the highest to lowest tertile
[17]. In south France, a case-control study of 437 breast
cancer cases and 922 controls showed an inverse asso-
ciation of olive oil intake with breast cancer risk [18].
In France, in a prospective study, Cottet et al. [19]
examined the association between dietary patterns and
breast cancer risk. The analyses included 2,381 postme-
nopausal invasive breast cancer cases diagnosed during
a median 9.7-year follow-up period (1993-2005) among
65,374 women from the E3N-EPIC cohort. Results
showed that the “healthy/Mediterranean” pattern was
negatively associated with breast cancer risk (hazard
ratio = 0.85, 95%CI 0.75 to 0.95; P = 0.003 for linear
trend), especially when tumors were estrogen receptor-
positive/progesterone receptor-negative. Authors con-
cluded that adherence to a dietary pattern including
mostly fruits, vegetables, fish, and olive/sunflower oil,
along with avoidance of Western-type foods, could
result in a substantial reduction in postmenopausal
breast cancer risk [19]. Finally, in France, in another
study, a positive association of monounsaturated fat
intake with breast cancer risk was found [20].
A n o t h e rs t u d y ,t h eE U R A M I Cs t u d y ,u s e da d i p o s e
biopsies with diverse fat intake patterns from 5 Eur-
opean centres, including southern Europe (Malaga,
Spain), to see if oleic acid or other monounsaturates are
associated with breast cancer. In 291 postmenopausal
incident breast cancer patients and 351 controls the OR
(75
th to 25
th percentiles) was 0.40 in Malaga and 1.27
(not statistically significant) in all the other centres
pooled. Thus, the strong inverse association between
oleic acid concentrations and breast cancer in the Span-
ish study population was not observed in the study’s
non-Spanish populations [21].
Colorectal cancer
A number of case-control and prospective studies indi-
cate that there is no appreciable association between
intake of total, saturated, monounsaturated, or polyunsa-
turated fat intakes, in general, with the risk of colorectal
cancer, or that the existing results are unconvincing
[22-24].
Examining the association of olive oil and monounsa-
turated fat intake mainly in Mediterranean populations,
with colorectal cancer in case-control studies, olive oil
has been found to have a slight protective effect, while
monounsaturated fat intake appeared uninfluential. In
an Italian study of 1953 patients with colorectal
carcinoma (1225 colon and 728 rectum) and 4154 con-
trols, the ORs for successive tertiles, compared with the
lowest one, were 0.87 (95%CI 0.75 to 1.01) and 0.83
(95%CI 0.70 to 0.99) (p = 0.03) when colorectal carci-
noma was analyzed as a whole, 0.82 (95%CI 0.68 to
0.98) and 0.81 (95%CI, 0.66 to 0.99) (p = 0.04) for colon
carcinoma, and 0.96 (95%CI 0.77 to 1.19) and 0.88 (95%
CI 0.66 to 1.12) for rectal carcinoma. After allowance
for vegetable intake, results were in the same direction,
not statistically significant [25]. In the same sample
[26,27] monounsaturated fat intakes appeared uninfluen-
tial [28]. Results towards the same direction were pre-
sented by Benito et al. [29] in 1991 [4,29]. When,
patients from Switzerland were examined together
(recruited from 1992 to 2000, 1394 colon cancer cases,
886 rectal cancer cases and 4765 controls), the OR for
an increment of one portion of fried foods per week was
0.89 for colon cancer, 0.97 for rectum and 0.93 for col-
orectum, for the use of olive oil [30].
Other studies examining the role of monounsaturated
fat in colorectal cancer outside of the Mediterranean
basin were not taken into consideration, because in
these countries monounsaturated fat may derive from
sources other than olive oil [31-33].
Prostate cancer
In three case-control studies, neither monounsaturated
lipids deriving mainly from olive oil nor olive oil per se
were found to be associated with prostate cancer risk. In
a case-control study in Greece, 320 patients with histo-
logically confirmed incident prostate cancer and 246
controls were included [34]. Among added lipids, after
adjustment for total energy intake among others, olive
oil was unrelated to the risk (p = 0.66), though monoun-
saturated fats, largely deriving from meat or olive oil,
were positively associated (OR 1.05, 95%CI 0.75 to 1.48,
p = 0.77). As it is stated, this contradiction could in part
be explained by the high content of vitamin E in olive
oil, which was significantly inversely related to prostate
cancer risk (OR 0.53, 95%CI 0.30 to 0.94, p = 0.03). In
another population-based case-control study in New
Zealand, after adjusting for energy intake, 317 prostate
cancer cases and 480 controls completed a food-fre-
quency questionnaire, in which for monounsaturated
fatty acids-rich vegetable oils, a single question was
asked about usual consumption of olive oil, canola or
peanut oil, collectively, whereas biomarkers for fatty
acids were measured in erythrocytes [35]. Increased con-
sumption of MUFA-rich vegetables oils (not total
MUFA, or MUFA of animal origin) was inversely asso-
ciated with prostate cancer risk. Thus, according to the
authors, a specific cancer-protective effect could be
attributed to non-MUFA components of vegetable oils,
as the antioxidant components of olive oil. In another
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men aged (< 70 years) with histologically confirmed
prostate cancer (Gleason grade > 5) and 905 age-fre-
quency-matched men, higher consumption of olive oil
(> 0.25 and < 0.25 l/month compared to non-consump-
tion) had an OR = 0.8 (p for trend = 0.12) [36]. There
was evidence for an inverse association of oleic acid
with prostate risk with a marginal non-significance,
which seems difficult to interpret, because olive oil only
supplied 8% of oleic acid consumed.
Monounsaturated fat intakes and their association
with prostate cancer in different countries than Mediter-
ranean were not taken into consideration, since a major
source of monounsaturated fat in North America, for
example, is meat [37-39].
Cancer of the larynx
Concerning laryngeal cancer, a protective effect of olive
oil intake was found in cross-sectional studies. An analy-
sis was performed in the combined dataset from two
case-control studies (1986-2000) conducted in northern
Italy and Switzerland for 68 women less than 79 years,
with histologically confirmed cancer of the larynx and
340 controls. After multivariate adjustment, an inverse
association was found between high versus low intake of
olive oil and laryngeal cancer (OR = 0.28, 95% CI 0.09
to 0.89) [40]. Olive oil has been related to a better prog-
nosis to male laryngeal cancer patients, whereas, the
same study group published a study in which the occur-
rence of new primaries among male laryngeal cancer
patients was lowered by one-third with higher intake of
monounsaturated fatty acids [41,42]. In another study
conducted in the same countries, with 527 histologically
confirmed laryngeal cancer cases and 1297 controls, an
inverse association of the risk was observed with olive
oil (OR = 0.4 for the highest compared to the lowest
quintile of intake, p = 0.003), not statistically significant
when controlling for total vegetable consumption (OR =
0.66, p = 0.45) [43]. Finally, in an analysis where cancers
of the oral cavity, pharynx other than nasopharynx, lar-
ynx and oesophagus were collectively assessed [44], olive
o i lu s e di ns a l a d sa n d / o ri nc o o k i n g ,w a ss i g n i f i c a n t l y
inversely associated (OR contrasting frequency of con-
sumption above versus below median = 0.78 with 95%
CI 0.67 to 0.90).
Cancer of the pharynx and the oral cavity
As it is stated in the paper by Garavello et al. [45] ana-
lysing the few prospective and case-control studies avail-
able, monounsaturated fats (and olive oil) seem to be
inversely related to oral and pharyngeal cancer risk. In a
case-control analysis in Italy (1992-1997), with 598 cases
and 1491 controls, risk was approximately halved in the
highest compared to the lowest quintile of olive oil (OR
= 0.4, 95%CI 0.3 to 0.7), which was slightly attenuated
b ya l l o w a n c ef o rv e g e t a b l ei n t a k e[ 4 6 ] .M o r e o v e r ,i na
recently conducted case-control study in Servia which
included 45 cases with histopathological diagnosis of
undifferentiated carcinoma of nasopharyngeal type
(UCNT), and 90 controls, frequent/moderate consump-
tion of olive oil was significantly negatively associated
with UCNT compared with rare or never consumption
of olive oil (OR = 0.42, 95%CI 0.19 to 0.91, p = 0.03)
[47].
For oral cancer exclusively, in a case-control study in
Greece with 106 patients with oral carcinoma and an
equal number of controls, added lipids, which in Greece
are represented overwhelmingly with olive oil, were
found inversely significantly associated with oral carci-
noma risk (p = 0.04) [48]. The joint analysis of Lagiou
et al. [44], for oral, pharyngeal, laryngeal and oesopha-
geal carcinoma, confirmed the same results. Finally, in a
recently conducted case-control study in Greece in the
context of the European alcohol-related cancers and
genetic susceptibility in Europe project (239 incident
upper aerodigestive tract, UADT, cases and 194 hospital
controls), authors concluded that stricter adherence to
the Mediterranean diet was associated with a substantial
and significant decrease in UADT cancer risk (30% for a
two-unit increase in score), whereas after mutual adjust-
ment, no individual dietary component of this diet was
significantly associated with this risk [49].
Oesophageal cancer
In three case-control studies, one yields inconclusive
results for the association of monounsaturated lipids
with oesophageal cancer and two others show a signifi-
cant inverse association with olive oil intake. In Greece,
56 cases of adenocarcinoma and 43 cases of squamous
cell carcinoma were compared with 200 controls.
Neither for adenocarcinoma (OR = 1.07, 95%CI 0.72 to
1.60 between an increment of a marginal quintile in the
intake of monounsaturated lipids), nor for squamous
cell carcinoma (OR = 0.74, 95%CI 0.49 to 1.11 for the
same increment), an association with monounsaturated
lipids (mainly olive oil) was established [50,4].
In the second study (1992 to 1997) in northern Italy, 304
histologically confirmed squamous oesophageal carcinoma
cases and 743 controls were interviewed, after correction
for multiple confounders, olive oil intake showed a signifi-
cant reduction of cancer risk (OR = 0.4). Without adjust-
ment for total vegetable consumption, olive oil also
showed a significant reduction of cancer risk, with no
monotonic exposure association, that is, even consumers
of a minimal quantity of olive oil appeared to be at a
reduced risk for the disease, as consumers of a maximal
quantity (OR = 0.3, 95% CI = 0.1 to 0.5), for the highest
versus the lowest quintile of olive oil intake [51] and the
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turated fatty acids [52]. In a third case-control study in
France (208 cases and 399 controls), all males, for olive oil,
the OR for consumers versus non-consumers was 0.70
(95% CI 0.54 to 0.90) [53].
Stomach cancer
For stomach cancer, in Italy, 83 stomach cancer cases of
negative microsatellite instability (MSI) (a distinctive
molecular pathway of carcinogenesis) were dietary
assessed. Olive oil had a statistically significant protec-
tive effect (OR = 0.6, 95%CI 0.3 to 1.00, for the highest
versus the lowest tertile, p for trend = 0.05), whereas for
MSI + stomach cancer cases, olive oil had also a protec-
tive effect, not statistically significant across tertiles (OR
= 0.5, 95%CI 0.2 to 1.1, for the highest versus the lowest
tertile, p for trend = 0.07) [54]. A protective effect of
olive oil to stomach cancer was also detected in another
Italian case-control study [55].
Lung cancer
Evidence is scarce. In a hospital-based, case-control
study of lung cancer in Italy (342 with primary lung
cancer and 292 controls), use of olive oil found to offer
a protection towards lung cancer (OR = 0.67, 95%CI
0.45 to 0.99) [56]. Prospective studies on the association
of lung cancer with dietary fat were not taken into con-
sideration in countries, such as USA and Norway,
because monounsaturated fat intake was mainly from
sources other than olive oil [57-59].
Ovarian cancer
Evidence concerning olive oil in take in relation to ovar-
ian cancer risk is limited; in two case-control studies,
olive oil and monounsaturated fat (mainly olive oil)
intake had a protective effect. Firstly, in Greece (189
epithelial ovarian cancer cases and 200 controls), an
inverse relation of monounsaturated fat intake and risk
for ovarian cancer was found (OR = 0.80, 95%CI 0.65 to
0.99 for 1SD increase in consumption on a daily basis)
[60]. In a more recent case-control in Italy (1992 to
1999) 1031 cases and 2411 controls were included. After
correction for multiple confounders, a reduced risk of
ovarian cancer was observed for high intake of olive oil
(OR = 0.68, 95%CI 0.50 to 0.93, for the highest quintile,
compared with the lowest one), as well for higher intake
of monounsaturated fat and oleic acid [61,62]. Other
studies of diet and ovarian cancer were not taken into
consideration, since the information was collected in
non-Mediterranean countries [63,64].
Endometrial cancer
In three epidemiologic studies, there is a suggestion of a
protective effect. In a case-control in Switzerland and
northern Italy (274 endometrial cancer cases and 572
controls), after correction for energy intake, more fre-
quent consumption of olive oil was associated with a
decreased risk for endometrial cancer, though results
were not statistically significant (OR = 0.82 for highest
v s .l o w e s tt e r t i l e )[ 6 5 , 4 ] .T w o hospital case-control stu-
dies have been published from Greece. In the first one
(145 cases and 298 controls), the only statistically sug-
gestive association was the inverse one with monounsa-
turated fats (OR = 0.74, 95%CI 0.54 to 1.03) [66]. In the
second one (84 cases and 84 controls), a protective
effect of added lipids, which in the Greek diet are pri-
marily represented by olive oil, was highly suggestive
[67].
Pancreatic cancer
In two case-control studies, one yields inconclusive
results for the association of monounsaturated lipids
with pancreatic cancer, the second one shows a signifi-
cant inverse association with olive oil. In a hospital
case-control study conducted in Greece (181 cases and
181 hospital-181 hospital visitor controls), for a 1SD
increase of the energy-adjusted residual of monounsatu-
rated fat OR was 1.04 (95%CI 0.86 to 1.25) when com-
pared with hospital controls and for 1SD increase in
monounsaturated consumption OR was 0.97 (95%CI
0.80 to 1.17) compared to visitor controls, with no sta-
tistically significant association [68]. In northern Italy, in
a case-control study conducted between 1983-1992 (362
cases with histologically confirmed, pancreatic cancer
risk and 1502 controls), cancer risk was inversely asso-
ciated with consumption of olive oil (OR = 0.58 for sub-
sequent tertiles of intake) after allowance for
sociodemographic factors and tobacco smoking (ORs
were 0.76 for intermediate, and 0.60 for highest score of
intake and the risk was significant) [69,70]. Monounsa-
turated fat intakes and oleic acid intakes in different
countries than Mediterranean are not taken into consid-
eration, since major sources of monounsaturated fat in
North America is, for example, meat, and major sources
of oleic acid in these countries could be canola, cod-
liver, coconut, soybean, and almond oils [71-73].
Bladder cancer
In a case-control study in Belgium (200 cases and 386
controls) results showed that there was a statistically sig-
nificant inverse association between olive oil intake and
bladder cancer consistent with a linear dose-response
relationship: middle versus the lowest tertile (OR = 0.62,
95%CI 0.39 to 0.99) and the highest versus the lowest
tertile (OR = 0.47, 95%CI 0.28 to 0.78; p-trend = 0.002)
[74]. However, findings from another study conducted
by Riboli and colleagues [75], showed that in a Spanish
population with an average dietary pattern typical of
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was associated with a moderate increase at risk, which
disappeared after correction for saturated fat intake.
Meta-analysis of the studies
As mentioned above for the meta-analysis 19 studies
that evaluated solely olive oil intake were taken into
account (Table 3). In total, data from 13800 cancer
patients and 23340 controls were analysed in the present
work. The combined effect of the highest percentile of
olive oil intake compared with the lowest was highly sig-
nificant (p < 0.001). Particularly, people in the highest
group of olive oil consumption had 0.66-times lower
odds of having any type of cancer (logOR = -0.41 95%CI
-0.53 to -0.29) (Table 3) or 34% lower likelihood of hav-
ing any type of cancer. The effect-equality test that was
applied revealed that the study-specific effect size mea-
sures were heterogeneous (Cohran’s Q = 47.52, I
2 =
62%, p = 0.0002), but all to the same protective direc-
tion (Figure 1).
Then, the studies were categorized by type of cancer,
i.e., breast (n = 5 studies), digestive (i.e., colorectal, oral
cavity, pharynx and oesophagus, pancreatic) (n = 8 stu-
dies) and other. Compared with low intake, high olive
oil consumption was associated with lower odds of
developing breast cancer (logOR = -0.45, 95%CI -0.78 to
-0.12) and lower odds of developing a cancer of the
digestive system (logOR = -0.36 95%CI -0.50 to -0.21)
(Table 3). As regards the type of origin, in both Medi-
terranean and non-Mediterranean people that reported
olive oil intake were less likely to have developed any
type of cancer (Table 3). Heterogeneity of the effect-size
measures was observed in studies performed in the
Mediterranean region (n = 15, p = 0.0002), whereas no
heterogeneity was observed in non-Mediterranean stu-
dies (n = 4, p = 0.12).
Conclusion
Nutritional factors play a major role in cancer initiation
and development [76]. The present systematic review
and meta-analysis of observational studies revealed that,
overall, olive oil consumption was associated with lower
odds of cancer development. Most prominent results
were observed for breast cancer and cancers of the
digestive system, while the aforementioned relationship
was similar to studies performed in Mediterranean as
well as non-Mediterranean countries. Meta-analyses
have several weaknesses, due to inherent biases and dif-
ferences in study designs (different control for residual
confounding, different socio-demographic and other life-
style characteristics that may alter food habits), publica-
tion bias, etc [9]. The use of only case-control studies
may also limit the interpretation of the results as causal.
Moreover, in 2 studies no exact information about the
effect size was reported in the retrieved abstract; how-
ever, the direction of the effect was similar to the other
studies. Therefore, it could be speculated that the inabil-
ity to include these studies in the meta-analysis would
not alter the combined results. At this point it should
also be noticed that although it is acceptable to consider
Table 3 Meta-analysis of studies that evaluated the role of olive oil on cancer development.
Combined effect log OR 95% CI for log OR; p for heterogeneity
All studies (n = 19) -0.41 -0.53, -0.29; < 0.001
Type of cancer
Breast cancer (n = 5) -0.45 -0.78, -0.12; < 0.001
Digestive (n = 8) -0.36 -0.50, -0.21; 0.16
Other (n = 6) -0.41 -0.59,-0.23; 0.34
Region of origin
Mediterranean (n = 15) -0.43 -0.78, -0.12; 0.0002
Non-Mediterranean (n = 4) -0.37 -0.62, -0.13; 0.12
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Figure 1 Forest plot of studies that evaluated the association
between olive oil intake on cancer development (data are
presented as log Odds Ratios and the corresponding 95%CI).
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such as the highest vs. lowest, the use of an ordered
variable, like the effect sizes per incremental quintile
would be preferable; however, the available results did
not allow for such an analysis. Moreover, the analysis of
studies was focused only on those that evaluated raw
olive oil intake, in order to avoid the synergistic effect of
cooking. Nevertheless, the large number of studies
enrolled, makes the present work one of the few that
systematically evaluated the cancer- monousaturated
lipid (especially olive oil) associations.
Ecologic comparisons and meta-analysis of prospective
cohort studies suggest that cancer morbidity and mor-
tality are lower in Mediterranean countries, where olive
oil represents a substantial fraction of dietary fat [77].
Prospective studies show evidence that higher degree of
adherence to the Mediterranean diet is associated with a
reduced mortality for cancer of all types, examined in
one model[78]. According to a review, in Western coun-
tries, approximately 25% of the incidence of colorectal
cancer, 15% of breast cancer, and 10% of prostate, pan-
creas, and endometrial cancer could be prevented if tra-
ditional Mediterranean dietary patterns were followed
[79]. However, ecologic comparisons are characterized
by complex forms of confounding, thus, are difficult to
interpret [4], in addition, though the protective role of
Mediterranean diet has been advocated by several stu-
dies, mutual confounding among food groups and nutri-
ents, as plant foods and olive oil, have not been
addressed in depth, and, it is probable that available
Mediterranean dietary scales cannot capture all the
interrelations among a multitude of foods consumed
traditionally.
From ecologic comparison of 28 countries, 76% of
the inter-country variation in colorectal cancer inci-
dence rates could be attributed to three dietary factors:
meat, fish and olive oil, in combination; meat and fish
were found positively associated, whereas olive oil was
negatively associated. The authors stated that olive oil
could influence secondary bile acid patterns in the
colon that, in turn, might influence polyamine metabo-
lism in colonic cells reducing possibility to progression
from normal mucosa to adenoma and, eventually, car-
cinoma [80]. Also, olive oil seems to be inversely asso-
ciated with breast cancer risk, although there are no
robust data to consider. Less experimental and epide-
miologic evidence has been collected for the other
types of cancer, such as gynecological, urological and
respiratory cancers, and there are no available data for
haemopoietic malignancies. As it is stated previously,
most available studies till today are case-control ones
and in the majority of them total energy intake is con-
trolled for. Most of these studies are examining the
role of a series of different nutrients and are not exam-
ining the specific role of added fats, monounsaturated
fats (in Mediterranean countries) and in particular
olive oil, to the above mentioned different types of
cancer.
In addition, a recent meta-analysis of biomarkers of
dietary fatty acid intake and risk of breast cancer con-
cluded that there is no significant association between
oleic acid and breast cancer risk in case-control studies,
whereas in cohort studies there was significant higher
risk for women with high levels of this fatty acid [81].
These papers referred were not taken into consideration,
because it was not clear from the studies that oleic acid
was deriving from olive oil only or from other dietary
sources as well. Also, selection and nutrient-specific
information biases are reported to be minimized in
some of the studies taken into consideration, while
others have also provided additional results after taking
into consideration the mutual confounding by different
food groups and nutrients, such as of olive oil and vege-
tables. Finally, though there is not enough data for skin
cancer, it could be stated that due to the high concen-
trations of squalene in olive oil, which is transferred to
the skin, olive oil intake could be searched for a protec-
tive effect against skin cancer [5].
Evidence to support that olive oil conveys protection
against occurrence of different types of cancer necessi-
tates more epidemiological studies, especially prospec-
tive ones, specifically designed to address these issues,
w h i c hw o u l da l la d j u s tf o rt o t a le n e r g yi n t a k e .T h e
ongoing and future well designed cohort studies will
help to further examine the association and questions
arising, such as, firstly if olive oil intake facilitates more
vegetable intake, thus, maximising its beneficial effects
to cancer prevention, and secondly, if the possible bene-
ficial effects of olive oil are attributed to its monounsa-
turated content or to its other components, could be
addressed [1,8,82]. Large enough and well conducted
trials, both for countries with high as with low intake of
olive oil, could be necessary, for the purpose of
generalisability.
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